Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
30
2026

How 2026 Code Changes Shifted SRT from Sensus Healthcare to a Standard Treatment Option

For nearly a century, surgical excision and Mohs surgery have been the gold standard for treating patients who have non-melanoma skin cancer (NMSC) and keloid disease. The surgery works extremely well – with cure rates…

November
30
2017

Should I Get the SRT-100 for My Practice?

Superficial radiation therapy was first used to treat non-melanoma skin cancers, such as basal cell and squamous cell carcinomas, back in the 1970s. For the last few decades, the treatment method fell out of use…

November
30
2017

The Best Keloid Scar Treatment Options

If you have keloid scars, chances are you’ve struggled with them for a while. These scars are notorious for their ability to resist attempts to treat or remove them, and often regrow a few years…

October
31
2017

The Latest Treatment Option for Non-Melanoma Skin Cancers

The Incidence of Non-Melanoma Skin Cancer in the United States Skin cancer is the most common form of cancer in the United States. Did you know it is currently estimated that one in five Americans…

October
30
2017

What is Superficial Radio Therapy? (SRT)

What is Superficial Radio Therapy? Superficial Radio Therapy is the latest non-invasive, non-melanoma skin cancer treatment option. Superficial Radio Therapy is administered with the use of the SRT-100™, our state-of-the-art system inspired by the tried-and-true…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry